Aurobindo Pharma Ltd stock quote, Aurobindo Pharma Ltd company overview #pharmaceutical #companies #usa


Posted On Nov 30 2017 by

#aurobindo pharma

#

Aurobindo Pharma Ltd (ARBN.NS)

Indian shares closed slightly higher on Wednesday, led by drug maker Aurobindo Pharma Ltd after stellar quarterly results, but sentiment remained edgy as investors awaited further cues on whether the U.S. Federal Reserve will raise interest rates this year.

Aug 24 Indian shares closed slightly higher on Wednesday, led by drug maker Aurobindo Pharma Ltd after stellar quarterly results, but sentiment remained edgy as investors awaited further cues on whether the U.S. Federal Reserve will raise interest rates this year.

Aug 24 Indian shares crept up on Wednesday, led by drug maker Aurobindo Pharma Ltd after stellar quarterly results, but sentiment remained edgy as investors awaited further clues on whether the Federal Reserve will raise U.S. interest rates this year.

– Note: Reuters has not verified this story and does not vouch for its accuracy

** Shares of India’s pharmaceutical companies rise, with the Nifty Pharma Index gaining as much as 1.13 pct, its biggest in nearly four months

MUMBAI Aurobindo Pharma Ltd. India’s fourth-largest drugmaker by sales, said higher sales in the United States and emerging markets helped its fourth-quarter net profit grow 40 percent, above estimates, sending shares up as much as 4 percent.

MUMBAI, May 31 Aurobindo Pharma Ltd, India’s fourth-largest drugmaker by sales, said higher sales in the United States and emerging markets helped its fourth-quarter net profit grow 40 percent, above estimates, sending shares up as much as 4 percent.

** India’s Aurobindo Pharma gains as much as 5.1 pct, highest since Feb. 1, on U.S. FDA approval for its epilepsy prevention drug lacosamide

Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world’s largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

Information, analytics and exclusive news on financial markets – delivered in an intuitive desktop and mobile interface

Everything you need to empower your workflow and enhance your enterprise data management

Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks

Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology

The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs

The industry leader for online information for tax, accounting and finance professionals


Last Updated on: November 30th, 2017 at 8:21 pm, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *